Full-Time

VP – Business Development

Confirmed live in the last 24 hours

Sana Biotechnology

Sana Biotechnology

201-500 employees

Develops engineered cell therapies for diseases

Biotechnology
Healthcare

Compensation Overview

$325k - $375kAnnually

Expert

San Bruno, CA, USA

Category
Business Development
Business & Strategy
Requirements
  • At least 9+ years of business development experience in the life sciences sector and 12+ years of experience in drug development are required
  • Experience leading and negotiating complex transactions required (licensing experience required, acquisition experience preferred)
  • Experience with drug development; familiarity within the field of cell and gene therapy is preferred
  • Experience leading cross-functional business development diligence and deal teams, including in areas outside of technical expertise
  • Expert executive communication skills; highly capable of articulating Sana's value proposition and partnering interests too varied audiences
  • Strong influencing skills (e. g. up, down and across), preferably with experience navigating and influencing stakeholders with and without authority
  • Strong decision-maker, able to appropriately articulate and balance tradeoffs in areas of high complexity
  • Excellent analytical and strategic capabilities
Responsibilities
  • Lead the sourcing and negotiation of partnership(s) with pharmaceutical companies for development and commercialization of existing Sana program(s) or platforms
  • Lead the proactive sourcing (including landscaping efforts for prioritized areas of interest), evaluation and negotiation of high-impact collaborations, licensing, equity, and acquisition opportunities
  • Enable and lead robust decision-making through all stages of deals, including seeking approval for transactions from the Executive Team and Board of Directors
  • Oversee negotiations strategies with prospective partners, including creating collaboration structures aligned with scientific and business needs and making deal recommendations to key executive team stakeholders
  • Develop and oversee the execution of short- and long-range business development strategies aligned with the priorities and interests of Sana's corporate strategy
  • Concurrently manage multiple projects of complex business opportunities. Requires prioritizing projects with key stakeholders and aligning with corporate goals
  • Set, communicate, and drive implementation of the partnering strategy in collaboration with executive team stakeholders
  • Oversee ongoing and active development of world-class business development capabilities, processes and practices
  • Establish collaborative relationships with key internal functions (R&D, Tech Ops, Legal and Finance) to ensure strong relationships with and support for the BD transactions
  • Be an ambassador for Sana at external meetings, conferences, and seminars to access new opportunities and develop external networks
  • Ensure high-quality opportunity assessments and due diligence reviews
  • Accountable for the achievement of important goals that impact and contribute to the mission of Sana
  • Demonstrate ability to engage and effectively influence team members across diverse teams while prioritizing multiple projects and meeting deadlines
  • Drive curiosity, scientific rigor and excellent problem-solving skills across a fast-paced, performance-driven environment
  • Natural ability to assess talent to help grow the organization and add to Sana's culture

Sana Biotechnology develops engineered cells aimed at treating and potentially curing various diseases. Their approach focuses on addressing the root causes of diseases by repairing genes within cells or replacing damaged cells. This method allows for the creation of new types of medicines that can enhance patient outcomes. Sana's main clients include healthcare providers, research institutions, and pharmaceutical companies seeking advanced therapeutic solutions. The company invests heavily in research and development to discover and create new treatments, which they monetize through licensing agreements, partnerships, and direct sales. Unlike many competitors, Sana's focus on cellular and genetic medicine positions them uniquely in the biotechnology sector. Their goal is to lead in the development of therapies that improve patient care by targeting diseases at their genetic and cellular origins.

Company Stage

IPO

Total Funding

$798.6M

Headquarters

Seattle, Washington

Founded

2018

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-7%

2 year growth

-17%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Fast Track designation for SC291 boosts potential in autoimmune disease treatment.
  • New Bothell facility enhances production capacity for engineered cell therapies.
  • $189.75 million PIPE offering indicates strong investor confidence in Sana's innovation.

What critics are saying

  • Increased competition from companies like BlueRock Therapeutics in regenerative medicine.
  • Resignation of key R&D figure, Dr. Douglas Williams, may disrupt innovation pipeline.
  • Reliance on PIPE offerings suggests potential financial instability or funding needs.

What makes Sana Biotechnology unique

  • Sana focuses on engineered cells to treat diseases at genetic and cellular levels.
  • The company targets unmet medical needs with innovative cellular and genetic therapies.
  • Sana's hypoimmune CAR T therapies offer novel solutions for autoimmune diseases.

Help us improve and share your feedback! Did you find this helpful?